The Global Coronary Stents Market was valued at USD 6.7 billion in 2025 and is estimated to grow at a CAGR of 8.2% to reach USD 14.6 billion by 2035.
Market growth is driven by the rising prevalence of cardiovascular diseases, an aging population, advancements in stent technologies, and the increasing adoption of minimally invasive procedures. Coronary stents are tubular devices inserted into narrowed or blocked coronary arteries to maintain vessel patency, enhance blood flow, and prevent heart attacks. The growing incidence of coronary artery disease, a leading cause of mortality worldwide, is fueling demand. Technological innovations such as drug-eluting stents, bioresorbable scaffolds, and polymer-free stents improve long-term outcomes by minimizing restenosis and thrombosis. Rising patient awareness, clinician confidence, and the expansion of revascularization procedures further support adoption. Trends such as the shift toward drug-eluting and biodegradable stents, as well as patient-centric approaches, are shaping industry growth globally.
The drug-eluting stent segment held a share of 84.8% in 2025 owing to its ability to minimize restenosis, enhance long-term patient outcomes, and support minimally invasive interventions. Drug-eluting stents release medication to prevent excessive tissue growth, providing superior long-term results compared to bare-metal stents, which reinforces their widespread clinical adoption.
The cobalt-chromium alloy segment is expected to reach USD 7.5 billion by 2035. Cobalt-chromium stents offer high tensile strength and durability, maintaining vessel expansion under arterial pressure while allowing thinner strut designs. These thinner struts reduce arterial injury, improve blood flow, and accelerate healing, while minimizing the risk of restenosis and thrombosis, driving segment growth.
North America Coronary Stents Market held a 39.6% share in 2025. The U.S. faces a significant burden of cardiovascular diseases, driven by sedentary lifestyles, high-fat diets, and stress, which increases the demand for coronary stent procedures. The region’s advanced healthcare infrastructure, specialized cardiac centers, and skilled medical professionals ensure widespread availability of stenting procedures. The adoption of innovative stent technologies across hospitals and interventional cardiology centers further fuels regional growth.
Prominent players in the Global Coronary Stents Market include Abbott, Medtronic, Boston Scientific, Biotronik, MicroPort Scientific, Stryker, Terumo, B. Braun, Biosensors International Group, Cook Medical, GENOSS, Elixir Medical, Andramed, Meril Life Science, and Sahajanand Laser Technology Limited. Companies in the Global Coronary Stents Market are strengthening their positions through continuous research and development to enhance stent safety, performance, and drug delivery capabilities. Firms are expanding their global footprint by entering emerging markets and forging partnerships with hospitals and healthcare providers. They focus on patient-centric and minimally invasive solutions, including bioresorbable and polymer-free stents, while integrating digital monitoring and smart stent technologies. Strategic marketing campaigns, clinician training programs, and collaborations with leading cardiac centers help companies improve adoption, build brand trust, and maintain a competitive edge in the global coronary stents industry.
This product will be delivered within 2-4 business days.
Market growth is driven by the rising prevalence of cardiovascular diseases, an aging population, advancements in stent technologies, and the increasing adoption of minimally invasive procedures. Coronary stents are tubular devices inserted into narrowed or blocked coronary arteries to maintain vessel patency, enhance blood flow, and prevent heart attacks. The growing incidence of coronary artery disease, a leading cause of mortality worldwide, is fueling demand. Technological innovations such as drug-eluting stents, bioresorbable scaffolds, and polymer-free stents improve long-term outcomes by minimizing restenosis and thrombosis. Rising patient awareness, clinician confidence, and the expansion of revascularization procedures further support adoption. Trends such as the shift toward drug-eluting and biodegradable stents, as well as patient-centric approaches, are shaping industry growth globally.
The drug-eluting stent segment held a share of 84.8% in 2025 owing to its ability to minimize restenosis, enhance long-term patient outcomes, and support minimally invasive interventions. Drug-eluting stents release medication to prevent excessive tissue growth, providing superior long-term results compared to bare-metal stents, which reinforces their widespread clinical adoption.
The cobalt-chromium alloy segment is expected to reach USD 7.5 billion by 2035. Cobalt-chromium stents offer high tensile strength and durability, maintaining vessel expansion under arterial pressure while allowing thinner strut designs. These thinner struts reduce arterial injury, improve blood flow, and accelerate healing, while minimizing the risk of restenosis and thrombosis, driving segment growth.
North America Coronary Stents Market held a 39.6% share in 2025. The U.S. faces a significant burden of cardiovascular diseases, driven by sedentary lifestyles, high-fat diets, and stress, which increases the demand for coronary stent procedures. The region’s advanced healthcare infrastructure, specialized cardiac centers, and skilled medical professionals ensure widespread availability of stenting procedures. The adoption of innovative stent technologies across hospitals and interventional cardiology centers further fuels regional growth.
Prominent players in the Global Coronary Stents Market include Abbott, Medtronic, Boston Scientific, Biotronik, MicroPort Scientific, Stryker, Terumo, B. Braun, Biosensors International Group, Cook Medical, GENOSS, Elixir Medical, Andramed, Meril Life Science, and Sahajanand Laser Technology Limited. Companies in the Global Coronary Stents Market are strengthening their positions through continuous research and development to enhance stent safety, performance, and drug delivery capabilities. Firms are expanding their global footprint by entering emerging markets and forging partnerships with hospitals and healthcare providers. They focus on patient-centric and minimally invasive solutions, including bioresorbable and polymer-free stents, while integrating digital monitoring and smart stent technologies. Strategic marketing campaigns, clinician training programs, and collaborations with leading cardiac centers help companies improve adoption, build brand trust, and maintain a competitive edge in the global coronary stents industry.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Type, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Material, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 10 Company Profiles
Companies Mentioned
The companies profiled in this Coronary Stents market report include:- Abbott
- Andramed
- B. Braun
- Biosensors International Group
- Biotronik
- Boston Scientific
- Cook Medical
- Elixir Medical
- GENOSS
- Medtronic
- Meril Life Science
- MicroPort Scientific
- Sahajanand Laser Technology Limited
- Stryker
- Terumo
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | March 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 6.7 Billion |
| Forecasted Market Value ( USD | $ 14.6 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
